FibroBiologics, Inc. Common StockFBLGNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank60
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-37.75%
↑ 42% vs avg
Percentile
P60
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-65.01%
Historical baseline
PeriodValue
2025-37.75%
2024-85.92%
2023-57.43%
2022-188.37%
2021-20.62%
20200.00%